Weighted Average Number of Shares Outstanding, Basic of Nuo Therapeutics, Inc. from 31 Mar 2013 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Nuo Therapeutics, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 31 Mar 2013 to 30 Sep 2025.
  • Nuo Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2025 was 47,539,384, a 4.2% increase year-over-year.
  • Nuo Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 45,424,437, a 8% increase from 2023.
  • Nuo Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 42,077,811, a 5.2% increase from 2022.
  • Nuo Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 40,001,089, a 32% increase from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Nuo Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 47,539,384 +1,925,472 +4.2% 01 Jul 2025 30 Sep 2025 10-Q 30 Oct 2025 2025 Q3
Q2 2025 46,823,111 +2,165,369 +4.8% 01 Apr 2025 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 46,816,114 +2,574,598 +5.8% 01 Jan 2025 31 Mar 2025 10-Q 30 Apr 2025 2025 Q1
Q4 2024 45,424,437 +3,346,626 +8% 01 Oct 2024 31 Dec 2024 10-K 01 Apr 2025 2024 FY
Q3 2024 45,613,912 +3,471,771 +8.2% 01 Jul 2024 30 Sep 2024 10-Q 30 Oct 2025 2025 Q3
Q2 2024 44,657,742 +2,858,726 +6.8% 01 Apr 2024 30 Jun 2024 10-Q 31 Jul 2025 2025 Q2
Q1 2024 44,241,516 +2,442,500 +5.8% 01 Jan 2024 31 Mar 2024 10-Q 30 Apr 2025 2025 Q1
Q4 2023 42,077,811 +2,076,722 +5.2% 01 Oct 2023 31 Dec 2023 10-K 01 Apr 2025 2024 FY
Q3 2023 42,142,141 +1,007,889 +2.4% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 41,799,016 +2,019,961 +5.1% 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024 2024 Q2
Q1 2023 41,799,016 +4,674,811 +13% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q4 2022 40,001,089 +9,704,713 +32% 01 Oct 2022 31 Dec 2022 10-K 19 Apr 2024 2023 FY
Q3 2022 41,134,252 +10,875,508 +36% 01 Jul 2022 30 Sep 2022 10-Q 20 Nov 2023 2023 Q3
Q2 2022 39,779,055 +9,520,311 +31% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 37,124,205 +6,865,461 +23% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 30,296,376 +4,604,128 +18% 01 Oct 2021 31 Dec 2021 10-K 17 Apr 2023 2022 FY
Q3 2021 30,258,744 +6,011,344 +25% 01 Jul 2021 30 Sep 2021 10-Q 04 Nov 2022 2022 Q3
Q2 2021 30,258,744 +6,011,344 +25% 01 Apr 2021 30 Jun 2021 10-Q/A 10 Aug 2022 2022 Q2
Q1 2021 30,258,744 +6,295,959 +26% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q4 2020 25,692,248 +1,969,848 +8.3% 01 Oct 2020 31 Dec 2020 10-K 15 Apr 2022 2021 FY
Q3 2020 24,247,400 +525,000 +2.2% 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2022 2021 Q3
Q2 2020 24,247,400 +525,000 +2.2% 01 Apr 2020 30 Jun 2020 10-K 15 Apr 2022 2021 FY
Q1 2020 23,962,785 +240,385 +1% 01 Jan 2020 31 Mar 2020 10-K 15 Apr 2022 2021 FY
Q4 2019 23,722,400 +443,836 +1.9% 01 Oct 2019 31 Dec 2019 10-K 15 Apr 2022 2021 FY
Q3 2019 23,722,400 0 0% 01 Jul 2019 30 Sep 2019 10-Q 31 Jan 2020 2019 Q3
Q2 2019 23,722,400 +791,209 +3.4% 01 Apr 2019 30 Jun 2019 10-Q 19 Aug 2019 2019 Q2
Q1 2019 23,722,400 +1,000,000 +4.4% 01 Jan 2019 31 Mar 2019 10-Q 20 May 2019 2019 Q1
Q4 2018 23,278,564 +8,632,452 +59% 01 Oct 2018 31 Dec 2018 10-K 16 Apr 2019 2018 FY
Q3 2018 23,722,400 +7,869,636 +50% 01 Jul 2018 30 Sep 2018 10-Q 31 Jan 2020 2019 Q3
Q2 2018 22,931,191 +13,004,079 +131% 01 Apr 2018 30 Jun 2018 10-Q 19 Aug 2019 2019 Q2
Q1 2018 22,722,400 +12,795,288 +129% 01 Jan 2018 31 Mar 2018 10-Q 20 May 2019 2019 Q1
Q4 2017 14,646,112 01 Oct 2017 31 Dec 2017 10-K 16 Apr 2019 2018 FY
Q3 2017 15,852,764 +5,925,652 +60% 01 Jul 2017 30 Sep 2017 10-Q 16 Nov 2018 2018 Q3
Q2 2017 9,927,112 +133,482 +1.4% 01 Apr 2017 30 Jun 2017 10-Q 13 Aug 2018 2018 Q2
Q1 2017 9,927,112 -116,023,988 -92% 01 Jan 2017 31 Mar 2017 10-Q 14 May 2018 2018 Q1
Q3 2016 9,927,112 01 Jul 2016 30 Sep 2016 10-Q 13 Nov 2017 2017 Q3
Q2 2016 9,793,630 -116,157,470 -92% 05 May 2016 30 Jun 2016 10-Q 14 Aug 2017 2017 Q2
Q1 2016 125,951,100 0 0% 01 Jan 2016 31 Mar 2016 10-Q 24 Oct 2016 2016 Q1
Q2 2015 125,951,100 +4,312,274 +3.5% 01 Apr 2015 30 Jun 2015 10-Q 13 Aug 2015 2015 Q2
Q1 2015 125,951,100 +14,728,259 +13% 01 Jan 2015 31 Mar 2015 10-Q 24 Oct 2016 2016 Q1
Q2 2014 121,638,826 01 Apr 2014 30 Jun 2014 10-Q 13 Aug 2015 2015 Q2
Q1 2014 111,222,841 +12,117,393 +12% 01 Jan 2014 31 Mar 2014 10-Q 14 May 2015 2015 Q1
Q1 2013 99,105,448 01 Jan 2013 31 Mar 2013 10-Q 15 May 2014 2014 Q1

Nuo Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 45,424,437 +3,346,626 +8% 01 Jan 2024 31 Dec 2024 10-K 01 Apr 2025 2024 FY
2023 42,077,811 +2,076,722 +5.2% 01 Jan 2023 31 Dec 2023 10-K 01 Apr 2025 2024 FY
2022 40,001,089 +9,704,713 +32% 01 Jan 2022 31 Dec 2022 10-K 19 Apr 2024 2023 FY
2021 30,296,376 +4,604,128 +18% 01 Jan 2021 31 Dec 2021 10-K 17 Apr 2023 2022 FY
2020 25,692,248 +1,969,848 +8.3% 01 Jan 2020 31 Dec 2020 10-K 15 Apr 2022 2021 FY
2019 23,722,400 +443,836 +1.9% 01 Jan 2019 31 Dec 2019 10-K 15 Apr 2022 2021 FY
2018 23,278,564 +8,632,452 +59% 01 Jan 2018 31 Dec 2018 10-K 16 Apr 2019 2018 FY
2017 14,646,112 01 Jan 2017 31 Dec 2017 10-K 16 Apr 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.